|
|
25 Upton Drive
Wilmington
MA
01887
United States
978-657-7500
|
|
PUBLIC
|
DUSA Pharmaceuticals, Inc.® is an integrated dermatology pharmaceutical company committed to improving people's health and confidence through its quality dermatological treatments. DUSA markets and continues to develop its Levulan® Photodynamic Therapy (PDT) technology platform, which is a treatment for the pre-cancerous skin lesions known as Actinic Keratoses (AK). DUSA is also developing certain internal indications of Levulan PDT.
DUSA's portfolio of complementary dermatology products includes ClindaReach®, which was acquired from Sirius Laboratories, Inc. ClindaReach is a topical acne treatment which includes a novel applicator for those hard-to-reach areas.
|
|
http://www.dusapharma.com/about-dusa.html
|
|
|
|
|
|
|
|
|
|
|